Ask Our Doctors and Nurses!

PREVACID Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

PREVACID Safety Reports

Total PREVACID reports: 63.
PREVACID FDA safety alerts: No.
Reported deaths: 2    Reported hospitalizations: 15.
Take PREVACID Side Effects Survey or Share Your PREVACID Story. Read More Here.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Jan 02, 2007. Female patient was diagnosed with gastrooesophageal reflux disease, hypertension and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, hip fracture, x-ray of pelvis and hip abnormal. PREVACID dosage: unknown. During the same period patient was treated with TORSEMIDE, DIOVAN. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2007. Female patient, 66 years of age, was diagnosed with gastrooesophageal reflux disease, hypertension and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood potassium decreased, blood sodium decreased, confusional state, diarrhoea, fall, head injury, hip fracture, memory impairment. PREVACID dosage: unknown. During the same period patient was treated with DIOVAN HCT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Dec 27, 2006. Female patient, 77 years of age, weighting 124.8 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: hip fracture. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with NORVASC, FOSAMAX. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 30, 2006. Female patient, weighting 16.98 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: fall, rickets, tibia fracture, vitamin d deficiency. PREVACID dosage: 7.5 MG, 2 IN 1 D, PER ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Jan 09, 2007. Male patient was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: vision blurred. PREVACID dosage: unknown. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 15, 2007. Female patient, 77 years of age, weighting 124.8 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: hip fracture. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with NORVASC, FOSAMAX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PREVACID problem on Jan 23, 2007. Male patient, 80 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: dysarthria, metabolic encephalopathy. PREVACID dosage: unknown. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Health Professional from UNITED STATES on Jan 30, 2007. Male patient, 80 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: metabolic encephalopathy. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with BACLOFEN, LIPITOR, METFORMIN, GLIPIZIDE, ATENOLOL, HYDROCHLOROTHIAZIDE, ASPIRIN, FLOMAX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Feb 12, 2007. Female patient, 66 years of age, was diagnosed with gastrooesophageal reflux disease, hypertension and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood potassium decreased, blood sodium decreased, cerebrovascular accident, confusional state, depression, diarrhoea, fall, head injury. PREVACID dosage: unknown. During the same period patient was treated with DIOVAN HCT. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Female patient, 66 years of age, was diagnosed with gastrooesophageal reflux disease, hypertension and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood potassium decreased, cerebrovascular accident, depression, fall, hip fracture, hip surgery, hyponatraemia, hypotension. PREVACID dosage: unknown. During the same period patient was treated with TORSEMIDE, DIOVAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Mar 05, 2007. Male patient, 47 years of age, weighting 197.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: diarrhoea, food poisoning, weight decreased. PREVACID dosage: SOLUTAB 30 MG 1/DAY PO. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, weighting 16.98 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: blood calcium increased, blood parathyroid hormone decreased, rickets, torus fracture, vitamin d deficiency. PREVACID dosage: 7.5 MG, 2 IN 1 D, PER ORAL. Patient recovered.

Physician from UNITED STATES reported PREVACID problem on Feb 28, 2007. Male patient, 56 years of age, was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, brain natriuretic peptide increased, bundle branch block left, oedema peripheral, panniculitis. PREVACID dosage: unknown. During the same period patient was treated with ASPIRIN, MICRO, IMDUR, PLAVIX, GLUCOTROL, HYDROCHLOROTHIAZIDE, BUMEX. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Male patient, 64 years of age, weighting 184.3 lb, was diagnosed with gastric ulcer haemorrhage, hiatus hernia and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: asthenia, condition aggravated, diarrhoea, fatigue, intraocular pressure increased. PREVACID dosage: unknown. During the same period patient was treated with IRON SUPPLEMENT, NIACIN. Patient recovered.

Consumer or non-health professional from CANADA reported PREVACID problem on Apr 03, 2007. Male patient, 33 years of age, was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: accident, jaw fracture. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, 51 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: dry eye, eye infection, eye pain, sinusitis, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATIVAN. Patient recovered.

Physician from UNITED STATES reported PREVACID problem on Apr 04, 2007. Female patient was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. PREVACID dosage: 7.5 MG, ONCE, ORAL. Patient died.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Male patient, child 9 years of age, weighting 54.10 lb, was diagnosed with stomach discomfort, vomiting, convulsion and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion. PREVACID dosage: 15 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with LUMINAL, DIASTAT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Apr 19, 2007. Male patient, 57 years of age, weighting 274.9 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dehydration, diabetes mellitus, dizziness, fall, influenza like illness, loss of consciousness, neuropathy, oedema peripheral. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PRINIVIL, TOPAMAX, ASPIRIN, LIPITOR, BYETTA, GLUCOPHAGE, GLUCOTROL, ACTOS. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2006. Female patient, 70 years of age, was diagnosed with gastrooesophageal reflux disease, poor peripheral circulation and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: tachycardia. PREVACID dosage: 30 MG QD ORAL. During the same period patient was treated with CILOSTAZOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Apr 24, 2007. Female patient, weighting 6.70 lb, was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: premature baby. PREVACID dosage: unknown. During the same period patient was treated with TRILEPTAL. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient, weighting 20.06 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, hypokinesia, nystagmus, vision blurred, visual disturbance, visual tracking test abnormal. PREVACID dosage: 7.5 MG, 2 IN 1 D, PER ORAL. During the same period patient was treated with ZANTAC. Patient recovered.

Health Professional from UNITED STATES reported PREVACID problem on May 04, 2007. Female patient, 60 years of age, weighting 170.4 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea, nervousness, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with PEPCID COMPLETE, CELEBREX, FLONASE, CLARITIN. Patient recovered.

PREVACID problem was reported by a Physician from UNITED STATES on May 07, 2007. Female patient was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. PREVACID dosage: 7.5 MG, ONCE, ORAL. Patient died on 03/14/2007.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on June 18, 2007. Female patient was diagnosed with gastrooesophageal reflux disease, impaired gastric emptying and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: impaired gastric emptying, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with REGLAN. Patient recovered.

PREVACID problem was reported by a Health Professional from UNITED STATES on July 03, 2006. Female patient, weighting 197.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease. PREVACID dosage: 15 MG QD. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on June 29, 2006. Female patient, 42 years of age, weighting 286.6 lb, was diagnosed with barrett's oesophagus and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: confusional state, csf oligoclonal band present, csf white blood cell count positive, hypertension, nuclear magnetic resonance imaging abnormal, nuclear magnetic resonance imaging brain abnormal, red blood cells csf positive, spinal disorder, vitamin b12 decreased. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with ALBUTEROL, THYROID. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2006. Female patient, 66 years of age, was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, tremor, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. Patient recovered.

Physician from UNITED STATES reported PREVACID problem on July 18, 2006. Female patient, 29 years of age, weighting 232.4 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: caesarean section, foetal heart rate abnormal, stillbirth. PREVACID dosage: 30 MG, 1 IN1 D, PER ORAL. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Female patient, 83 years of age, weighting 149.9 lb, was diagnosed with barrett's oesophagus and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, eye swelling, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with PEPCID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Aug 01, 2006. Female patient, 42 years of age, weighting 286.6 lb, was diagnosed with barrett's oesophagus and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: confusional state, headache, hypertension, multiple sclerosis, vitamin b12 decreased, vitamin b6 decreased, vitamin d decreased. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL; 30 MG, 2 IN 1 D, PER ORAL. During the same period patient was treated with ALBUTEROL, THYROID. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Male patient, 52 years of age, weighting 225.0 lb, was diagnosed with hiatus hernia and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: dyspepsia. PREVACID dosage: 30 MG DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Aug 14, 2006. Female patient, 60 years of age, was diagnosed with gastrooesophageal reflux disease, sinusitis and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: eye pain, headache, nausea, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with AUGMENTIN. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 83 years of age, weighting 149.9 lb, was diagnosed with barrett's oesophagus and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, eye swelling, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with PEPCID. Patient recovered.

Physician from UNITED STATES reported PREVACID problem on Sept 13, 2006. Male patient was diagnosed with oesophagitis and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: bacterial infection, sepsis, thrombocytopenia. PREVACID dosage: 7.5 MG, 2 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2006. Male patient, weighting 16.50 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: eczema, urticaria, viral infection. PREVACID dosage: 7.5MG QD PO. Patient recovered.

Health Professional from UNITED STATES reported PREVACID problem on Sept 18, 2006. Female patient, 59 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blister, blood glucose increased, diarrhoea, skin ulcer. PREVACID dosage: unknown. During the same period patient was treated with GLUCOPHAGE, GLUCOTROL. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Male patient, 47 years of age, was diagnosed with prophylaxis, transient ischaemic attack, breakthrough pain, migraine, hypertension and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: euphoric mood, fatigue, hypertension, hypotension, insomnia, loss of consciousness, migraine. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with HYDROMORPHONE, DEPAKOTE, KADIAN, CLONIDINE, NORTRIPTYLINE, LISINOPRIL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported PREVACID problem on Oct 16, 2006. Male patient, 17 years of age, weighting 180.0 lb, was diagnosed with gastritis and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: pruritus. PREVACID dosage: 30 MG ONCE A DAY PO. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, weighting 142.0 lb, was diagnosed with helicobacter infection and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, arthropathy, diarrhoea, dysgeusia, joint stiffness, joint swelling, musculoskeletal stiffness, oedema peripheral, pain in extremity. PREVACID dosage: unknown. During the same period patient was treated with BIAXIN, AMOXICILLIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Oct 20, 2006. Male patient, weighting 45.08 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: photophobia. PREVACID dosage: 2.5 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with SINGULAIR. Patient recovered.

PREVACID problem was reported by a Physician from UNITED STATES on Oct 20, 2006. Male patient, 87 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: encephalopathy. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with SPIRONOLACTONE, FUROSEMIDE, NADOLOL, LACTULOSE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Oct 24, 2006. Male patient was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: vision blurred. PREVACID dosage: 30 MG ORAL. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2006. Female patient was diagnosed with gastrooesophageal reflux disease, hypertension and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, hip fracture, x-ray of pelvis and hip abnormal. PREVACID dosage: unknown. During the same period patient was treated with TORSEMIDE, DIOVAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Oct 20, 2006. Female patient, 66 years of age, was diagnosed with gastrooesophageal reflux disease, hypertension and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood potassium decreased, blood sodium decreased, confusional state, diarrhoea, fall, head injury, hip fracture, memory impairment. PREVACID dosage: unknown. During the same period patient was treated with DIOVAN HCT. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2006. Male patient, weighting 45.08 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: photophobia, pigmentation disorder, retinal dystrophy, retinogram abnormal. PREVACID dosage: 2.5 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with SINGULAIR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Nov 08, 2006. Male patient, weighting 11.82 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: apnoea, flatulence, gastrooesophageal reflux disease, infantile spitting up, respiratory arrest, skin discolouration, treatment noncompliance. PREVACID dosage: unknown. During the same period patient was treated with REGLAN, ZANTAC. Patient was hospitalized. Patient recovered.

PREVACID problem was reported by a Physician from UNITED STATES on Dec 14, 2006. Female patient, weighting 108.0 lb, was diagnosed with gastritis, gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: folliculitis, gastroenteritis, rash maculo-papular. PREVACID dosage: 30 MG QD PO. Patient recovered.

Pharmacist from UNITED STATES reported PREVACID problem on Dec 19, 2006. Male patient, child 10 years of age, weighting 106.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, gastrooesophageal reflux disease. PREVACID dosage: unknown. Patient recovered.

PREVACID problem was reported by a Health Professional from UNITED STATES on Dec 22, 2006. Female patient, 46 years of age, weighting 203.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: non-cardiac chest pain. PREVACID dosage: unknown. During the same period patient was treated with PROTONIX. Patient recovered.

Pharmacist from UNITED STATES reported PREVACID problem on Dec 29, 2006. Female patient, 49 years of age, weighting 145.0 lb, was diagnosed with overdose and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: accidental overdose, blood pressure increased, dyspnoea, erythema, hyperhidrosis, infusion site erythema, infusion site rash, muscle twitching. PREVACID dosage: 30MG DAILY IV DRIP. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient, 62 years of age, weighting 180.4 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: cataract, eye pain, glaucoma, vision blurred. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ESTRACE, ASPIRIN, LIPITOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on July 19, 2007. Female patient, 43 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: visual field defect. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, 43 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: visual field defect. PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. Patient recovered.

Pharmacist from UNITED STATES reported PREVACID problem on Aug 02, 2007. Female patient, 46 years of age, weighting 308.2 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: diarrhoea. PREVACID dosage: 30 MG EVERY 12 HOURS PO. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2007. Female patient, 46 years of age, weighting 151.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: abdominal distension, alopecia, chest pain, diarrhoea, dizziness, headache, insomnia, nausea, neck pain. PREVACID dosage: 30 MG, 1 IN 1 D, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Aug 03, 2007. Male patient, 64 years of age, weighting 210.1 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: disorientation, dizziness, dyspnoea, visual disturbance. PREVACID dosage: 30 MG, 1 IN 1 D; ORAL. During the same period patient was treated with VITAMIN SUPPLEMENT. Patient recovered.

PREVACID problem was reported by a Physician from UNITED STATES on Aug 21, 2007. Male patient, weighting 14.00 lb, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: deafness. PREVACID dosage: 7.5 MG QD PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Sept 06, 2007. Female patient, weighting 120.0 lb, was diagnosed with barrett's oesophagus and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: anaemia, dyspnoea, joint swelling, oral pain, pallor, palpitations, weight decreased. PREVACID dosage: 1-30 MG TABLET DAILY IN AM PO. During the same period patient was treated with FAMOTIDINE. Patient recovered.

PREVACID problem was reported by a Pharmacist from UNITED STATES on Sept 12, 2007. Male patient, 79 years of age, weighting 172.0 lb, was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anorexia, asthenia, diarrhoea, gastrooesophageal reflux disease, hiatus hernia, overgrowth bacterial, weight decreased. PREVACID dosage: unknown. During the same period patient was treated with NEXIUM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PREVACID problem on Sept 13, 2007. Female patient, 60 years of age, weighting 140.0 lb, was diagnosed with abdominal discomfort, prophylaxis and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: early satiety, nausea, weight decreased. PREVACID dosage: unknown. Patient recovered.

PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2007. Female patient, child 5 years of age, weighting 141.1 lb, was diagnosed with vomiting and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: accommodation disorder, hallucinations, mixed, visual disturbance. PREVACID dosage: 15 MG DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PREVACID problem on Sept 19, 2007. Female patient, child 11 years of age, weighting 90.00 lb, was diagnosed with gastrooesophageal reflux disease, stomach discomfort and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, malaise, pain. PREVACID dosage: 30 MG ONCE A DAY PO. Patient recovered.